Cardiac arrhythmia is associated with increased mortality and morbidity in patients with chronic kidney disease (CKD) (McCullough & Sandberg, 2004). The implantable cardioverter defibrillator (ICD) has been shown to decrease mortality of patients with cardiac arrhythmias, yet CKD patients are usually excluded from clinical trials. This article discusses the ICD as it relates to CKD patients, including care of the patient and possible complications that can be encountered.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!